| Financial Year |
June 30 2020 |
| Monetary Funds |
731,473,515.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,600,000.00 |
| Accounts Receivable |
205,241,252.00 |
| Advances to Suppliers |
6,642,167.00 |
| Other Receivables |
619,822.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
383,789,083.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,216,498.00 |
| Total Current Assets |
1,339,582,337.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
671,730,812.00 |
| Under-construction Projects |
35,929,352.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,466,259.00 |
| R&D expenses |
-- |
| Goodwill |
5,586,976.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
804,713,399.00 |
| Total Assets |
2,144,295,736.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
41,410,719.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,824,105.00 |
| Taxes Payable |
10,966,442.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,330,213.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
98,679,529.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,653,008.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,653,008.00 |
| Total Liabilities |
145,332,537.00 |
| Paid-In Capital(Or Share Stock) |
358,000,000.00 |
| Capital Surplus |
17,291,715.00 |
| Surplus Reserve |
128,215,585.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,495,455,899.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,998,963,199.00 |
| Owner's Equity（Stockholder's Equity） |
1,998,963,199.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,144,295,736.00 |
